Faeth Therapeutics raised $25 million in a strategic financing led by S2G Ventures to advance its lead program PIKTOR in endometrial cancer. The round includes participation from existing investors Khosla Ventures, Future Ventures, Digitalis Ventures, KdT Ventures, and Cantos, plus new investors B Capital Group, Avicella, and THO Seed Fund.
Comments
Want to join the conversation?
Loading comments...